EICHORPublic-registry site landscape for NCT05411861, “Post-Operative Pain and Opioid Reduction Trial After Bunionectomy”, a Hallux Valgus and Bunion study sponsored by Cali Pharmaceuticals LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05411861 (registry record) |
| Study title | Post-Operative Pain and Opioid Reduction Trial After Bunionectomy |
| Official title | Randomized, Double-Blind, Placebo- and Active-Controlled, Dose Escalation and Optional Dose Expansion Study to Evaluate Safety, Efficacy, and PK of CPL-01 in Post-Op Pain After Unilateral Distal First Metatarsal Bunionectomy + Osteotomy |
| Sponsor | Cali Pharmaceuticals LLC |
| Condition(s) | Hallux Valgus and Bunion |
| Phase | PHASE2 |
| Listed sites | 3 |
| Intervention(s) | Analgesic Non Narcotic |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT05411861.
Eichor generates a preliminary site-risk snapshot for NCT05411861 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
